These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1913233)

  • 1. Antitumor properties of phenothiazines.
    Motohashi N; Gollapudi SR; Emrani J; Bhattiprolu KR
    Cancer Invest; 1991; 9(3):305-19. PubMed ID: 1913233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenothiazines and calmodulin (review).
    Motohashi N
    Anticancer Res; 1991; 11(3):1125-64. PubMed ID: 1888146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The primary in vitro anticancer activity of "half-mustard type" phenothiazines in NCI's revised anticancer screening paradigm.
    Wuonola MA; Palfreyman MG; Motohashi N; Kawase M; Gabay S; Gupta RR; Molnár J
    Anticancer Res; 1998; 18(1A):337-48. PubMed ID: 9568100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on phenothiazines: New microtubule-interacting compounds with phenothiazine A-ring as potent antineoplastic agents.
    Ghinet A; Moise IM; Rigo B; Homerin G; Farce A; Dubois J; Bîcu E
    Bioorg Med Chem; 2016 May; 24(10):2307-17. PubMed ID: 27073050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The primary in vitro antitumor screening of "half-mustard type" phenothiazines.
    Wuonola MA; Palfreyman MG; Motohashi N; Kawase M; Gabay S; Nacsa J; Molnár J
    Anticancer Res; 1997; 17(5A):3409-23. PubMed ID: 9413180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New derivatives of phenothiazines with anticancer activities].
    Morak-Młodawska B; Jeleń M; Pluta K
    Pol Merkur Lekarski; 2009 Jun; 26(156):671-5. PubMed ID: 19711740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Azaphenothiazines - promising phenothiazine derivatives. An insight into nomenclature, synthesis, structure elucidation and biological properties.
    Pluta K; Jeleń M; Morak-Młodawska B; Zimecki M; Artym J; Kocięba M; Zaczyńska E
    Eur J Med Chem; 2017 Sep; 138():774-806. PubMed ID: 28734245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased lipid peroxidation, apoptosis and selective cytotoxicity in colon cancer cell line LoVo and its doxorubicin-resistant subline LoVo/Dx in the presence of newly synthesized phenothiazine derivatives.
    Środa-Pomianek K; Michalak K; Świątek P; Poła A; Palko-Łabuz A; Wesołowska O
    Biomed Pharmacother; 2018 Oct; 106():624-636. PubMed ID: 29990852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor activity of phenothiazine-related compounds.
    Nagy S; Argyelan G; Molnár J; Kawase M; Motohashi N
    Anticancer Res; 1996; 16(4A):1915-8. PubMed ID: 8712720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Action of some amines of the phenothiazine group and of several of their chloroethyl derivatives on Ehrlich sarcoma in the mouse].
    CARRAZ G; BOUCHERLE A; BERIEL SH; LUU DUC
    Therapie; 1962; 17():8-18. PubMed ID: 13876835
    [No Abstract]   [Full Text] [Related]  

  • 11. Possible Biological and Clinical Applications of Phenothiazines.
    Varga B; Csonka Á; Csonka A; Molnár J; Amaral L; Spengler G
    Anticancer Res; 2017 Nov; 37(11):5983-5993. PubMed ID: 29061777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor potential and possible targets of phenothiazine-related compounds.
    Motohashi N; Kawase M; Saito S; Sakagami H
    Curr Drug Targets; 2000 Nov; 1(3):237-45. PubMed ID: 11465073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multidrug resistance reversing activity of newly developed phenothiazines on P-glycoprotein (ABCB1)-related resistance of mouse T-lymphoma cells.
    Spengler G; Takács D; Horváth A; Riedl Z; Hajós G; Amaral L; Molnár J
    Anticancer Res; 2014 Apr; 34(4):1737-41. PubMed ID: 24692704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple non-psychiatric effects of phenothiazines: a review.
    Sudeshna G; Parimal K
    Eur J Pharmacol; 2010 Dec; 648(1-3):6-14. PubMed ID: 20828548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxicity and differentiation-inducing activity of phenothiazine and benzo[a]phenothiazine derivatives.
    Motohashi N; Sakagami H; Kamata K; Yamamoto Y
    Anticancer Res; 1991; 11(5):1933-7. PubMed ID: 1662929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pegylation of phenothiazine - A synthetic route towards potent anticancer drugs.
    Cibotaru S; Nastasa V; Sandu AI; Bostanaru AC; Mares M; Marin L
    J Adv Res; 2022 Mar; 37():279-290. PubMed ID: 35499049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential antitumor mechanisms of phenothiazine drugs.
    Qi L; Ding Y
    Sci China Life Sci; 2013 Nov; 56(11):1020-7. PubMed ID: 24132550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor Activity of PEGylated and TEGylated Phenothiazine Derivatives: Structure-Activity Relationship.
    Cibotaru S; Sandu AI; Nicolescu A; Marin L
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The in vitro antitumor assay of "half-mustard type" phenothiazines in screens of AIDS-related leukemia and lymphomas.
    Wuonola MA; Palfreyman MG; Motohashi N; Kawase M; Gabay S; Molnár J
    Anticancer Res; 1997; 17(5A):3425-9. PubMed ID: 9413181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of DNA fragmentation in human myelogenous leukaemic cell lines by phenothiazine-related compounds.
    Sakagami H; Takahashi H; Yoshida H; Yamamura M; Fukuchi K; Gomi K; Motohashi N; Takeda M
    Anticancer Res; 1995; 15(6B):2533-40. PubMed ID: 8669819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.